Dilon Diagnostics

37 articles about Dilon Diagnostics

• Dilon Diagnostics and GE Healthcare Win FDA Clearance of the Discovery NM 750b Biopsy Accessory

  11/28/2016

• Dilon Diagnostics And GE Healthcare Announce Exclusive North America Distribution Agreement For The Discovery NM750b Molecular Breast Imaging System

  11/16/2016

• Dilon Diagnostics And GE Healthcare Will Present GE Healthcare's FDA 510k Pending Dual Head MBI Localization Accessory For Breast Biopsy* At The SBI/ACR Breast Imaging Symposium In April 7-9

  4/7/2016

• Dilon Diagnostics And GE Healthcare Announce A Global Distribution Agreement For The Discovery NM750b Molecular Breast Imaging System

  11/25/2015

• Digirad Corporation Signs Exclusive International Distribution Agreement With Dilon Diagnostics

  8/22/2013

• Digirad Corporation Signs Exclusive International Distribution Agreement With Dilon Diagnostics

  8/22/2013

• Dilon Diagnostics Researchers Determine Molecular Breast Imaging to be a Useful Adjunct to Mammography

  5/2/2013

• Dilon Diagnostics Release: Researchers at Radiological Society of North America (RSNA) Determine Molecular Breast Imaging Improves Early Detection in High-Risk Women

  11/30/2012

• Dilon Diagnostics Release: Low-Dose Molecular Breast Imaging Marks a New Frontier in the Fight Against Breast Cancer

  10/29/2012

• Dilon Diagnostics Release: New Data Suggests Low-Dose Molecular Breast Imaging is Possible for Single-Head Imaging Systems

  8/16/2012

• Dilon Diagnostics Release: BSGI Molecular Breast Imaging Provides Better Results than MRI for Cancer Patients with Dense Breasts

  7/11/2012

• Dilon Diagnostics Release: BSGI Molecular Breast Imaging Proves Equivalent to MRI in Breast Cancer Patient Management

  7/11/2012

• Dilon Diagnostics Release: 3D Imaging in the Operating Room is set to Revolutionize Radio-Guided Surgeries

  5/10/2012

• Dilon Diagnostics Release: Adding BSGI Molecular Breast Imaging to Breast Imaging Centers Significantly Improves Breast Cancer Detection

  3/27/2012

• Dilon Diagnostics Release: Molecular Breast Imaging Is Superior to Ultrasound and Mammography for the Detection of Breast Cancer

  2/14/2012

• Dilon Diagnostics Release; BSGI/MBI Proven to Be Equivalent to MRI in the Detection of Breast Cancer

  11/30/2011

• Dilon Diagnostics Release: BSGI/MBI Enhances Pre-Surgical Planning For Patients With Newly Diagnosed Breast Cancer

  11/30/2011

• Dilon Diagnostics Release: BSGI/MBI: Effective for Detecting Breast Cancer In Dense and Non-Dense Breasts

  11/29/2011

• Dilon Diagnostics Release: BSGI/MBI Shows Greater Sensitivity and Comparable Specificity When Compared to Ultrasound and Mammography

  11/29/2011

• Dilon Diagnostics Signs Exclusive Distribution With SurgicEye(R)

  9/27/2011